The discomfort from gastrointestinal issues combined with the tingling sensations of topiramate can make the adjustment period challenging for some patients
D., Hansen, T., & Bain, S
doi: 10.1056/NEJMp2400978 Summary Keywords GIP, GLP-1, GLP-1RA, tirzepatide, diabetes, obesity, cardiovascular disease Citation Liu QK (2024) Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
For instance, in April 2023, Mitsubishi Tanabe Pharma Corporation, a Japan-based pharmaceuticals company, launched Mounjaro 2.5 mg or 5 mg Ateos
One mechanism involves regulation of invariant natural killer T cells (iNKT cells) in psoriatic plaques, plus AMPK activation that reduces keratinocyte proliferation